Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Multiple Myeloma × Immunotherapy × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Carcinoma, Hepatocellular 6 Melanoma 5 Squamous Cell Carcinoma of Head and Neck 4 Lung Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Triple Negative Breast Neoplasms 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm, Residual 2 Neoplasm Metastasis 2 Hyperthermia 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Uveal Melanoma 1 Turcot syndrome 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Recurrence 1 Radiation Pneumonitis 1 Prostatic Neoplasms 1 Pancreatic Cancer Liver Metastases 1 Neoplasms, Glandular and Epithelial 1

Interventions

Dexamethasone 294 Bortezomib 160 Lenalidomide 155 Cyclophosphamide 143 Melphalan 107 Calcium Dobesilate 93 daratumumab 82 pomalidomide 58 carfilzomib 58 fludarabine phosphate 53 Peripheral Blood Stem Cell Transplantation 53 Thalidomide 46 Filgrastim 46 Mycophenolic Acid 42 Busulfan 42 ixazomib 39 fludarabine 36 Granulocyte Colony-Stimulating Factor 35 Whole-Body Irradiation 34 Tacrolimus 34 dexamethasone acetate 29 Etoposide 28 Cyclosporine 28 Antilymphocyte Serum 27 isatuximab 25 dexamethasone 21-phosphate 24 auricularum 23 plerixafor 21 Radiotherapy 21 elotuzumab 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03634800 2021-08-05

RISE-M

Weill Medical College of Cornell University

Phase 2 Terminated

6 enrolled 11 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡